Pregnancy: how dysbiosis may affect placentation, maternal immunity, and the risk of neonatal sepsis
Maria Rescigno (Humanitas University, Rozzano, Milan) discusses the role of dysbiosis during pregnancy and the perinatal period, outlining two potential clinical trajectories.
CHMP has announced the development of a dedicated reflection paper on the non-clinical development and evaluation of microbiome-based medicinal products (MMPs).
Dietary protein influences V. cholerae growth, metabolism, virulence, and competition with gut microbes.
Some bacteria common in dog owners, particularly Streptococcus strains, were linked to fewer behavioral and attention problems.
Industry, Gastroenterology
Sponsored by
How postbiotics are reshaping dietary supplements and pharma: key insights from Humiome® Post LB.
Francesco Franceschi from Policlinico Universitario A. Gemelli IRCCS (Roma) focuses on bacterial translocation across a compromised intestinal barrier as a plausible pathway contributing to sepsis.
Lantibiotic-producing gut bacteria can prolong gut imbalance and increase susceptibility to dangerous infections after antibiotics.
MTB and aerolysin drive gut inflammation in ulcerative colitis.
William Fusco, gastroenterologist at Policlinico Universitario Agostino Gemelli, highlighted a recently published pilot study on post-infectious irritable bowel syndrome (IBS) framed within microbial precision medicine and biomarker-driven care.
Nutrient competition provides a predictive framework to anticipate and potentially mitigate drug side effects on the gut microbiota.
